Back
Cleveland-Cliffs, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
39
CLF
Cleveland-Cliffs, Inc.
Last Price:
$12.71
Seasonality Move:
6.63%
Sell
39
INKT
MiNK Therapeutics, Inc.
Last Price:
$12.42
Seasonality Move:
-18.07%
Sell
39
Cleveland-Cliffs, Inc. (CLF)
is a Sell
Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?
-
The current Cleveland-Cliffs, Inc. [CLF] share price is $12.71. The Score for CLF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $12.42. The Score for INKT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLF Stock Price Chart
What is Cleveland-Cliffs, Inc.'s stock price today?
-
The Cleveland-Cliffs, Inc. share price today is $12.71The current trend is moderately bullish and CLF is experiencing selling pressure, which indicates risk of future bearish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $12.42The current trend is relatively stagnant and INKT is experiencing slight selling pressure.
CLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 54.21 | Buy |
| Chaikin Money Flow: | -12267118 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.85 - 12.85) | Buy |
| Bollinger Bands (100): | (10.36 - 13.04) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 51.41 | Buy |
| Chaikin Money Flow: | -4658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.9 - 13.02) | Buy |
| Bollinger Bands (100): | (12.31 - 15.67) | Sell |
CLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.71 | Buy |
| 20-day SMA: | 12.19 | Buy |
| 50-day SMA: | 12.46 | Buy |
| 200-day SMA: | 9.96 | Buy |
| 8-day EMA: | 12.71 | Sell |
| 20-day EMA: | 12.39 | Buy |
| 50-day EMA: | 12.11 | Buy |
| 200-day EMA: | 11.16 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.19 | Buy |
| 20-day SMA: | 11.57 | Buy |
| 50-day SMA: | 13.1 | Sell |
| 200-day SMA: | 11.81 | Buy |
| 8-day EMA: | 12.21 | Buy |
| 20-day EMA: | 12.1 | Buy |
| 50-day EMA: | 12.78 | Sell |
| 200-day EMA: | 12.24 | Buy |
Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $2.71 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Cleveland-Cliffs, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||